ALC

Alcon Inc.

Healthcare · $31.8B market cap

Verdict

Share price

$63.76

close of Oct 3, 2026

Fair value

$73.86

Sticker Price

Payback Price

$29.55

buy price

Undervalued

ALC is Undervalued: at $63.76 it trades 14% below its fair value of $73.86. Its buy price (Payback Price) is $29.55, 54% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow. Sales grew 6% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth33.4% a year✓
Equity per share growth3.2% a year✗
Sales growth5.1% a year✗
Free cash flow growth4.6% a year✗
Return on invested capital3.9%✗

Follow ALC

Get notified when it reaches its buy price of $29.55. Free.

Create a free account

Superinvestors

2 of the investors we track hold ALC. In Q2 2026, 1 added and 1 sold out. Who we track

Moves in Q2 2026

Added: Lee Ainslie

Sold out: William Von Mueffling

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical…

Medical - Specialties

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works